How is the OnKure Therapeutics Inc. - Ordinary Shares - Class A today?

The OnKure Therapeutics Inc. - Ordinary Shares - Class A today is trading in the green, up by 5.45% at 2.32.

How has OnKure Therapeutics Inc. - Ordinary Shares - Class A performed historically?

The OnKure Therapeutics Inc. - Ordinary Shares - Class A is currently trading up 5.45% on an intraday basis in the past week the index rose 18.97%. The index has been down -59.30% in the past quarter and fell None% in the past year. You can view this in the overview section.

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Annual Net Profit?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Annual Net Profit fell 49.17% in the last year to $52.67 M. Its sector's average net profit growth for the last fiscal year was -11.16%.

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Price to Earning Ratio?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Price to Earning Ratio is -0.45, which is negative.

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Stock Price?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Stock Price rose 18.97% outperformed its sector by 18.16% in the past week.

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Quarterly Net profit?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Quarterly Net profit fell 67% YoY to $15.92 M. Its sector's average net profit growth YoY for the quarter was -200.49%.

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Debt to Equity Ratio?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Return on Equity(ROE)?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -5,304.43%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Mutual Fund Holding?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Mutual Fund Holding decreased by 0.01% in the last quarter to 7.01.

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Interest Coverage Ratio?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Interest Coverage Ratio is -174.58, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is OnKure Therapeutics Inc. - Ordinary Shares - Class A Institutional Holding?

OnKure Therapeutics Inc. - Ordinary Shares - Class A Institutional Holding increased by 0.83% in the last quarter to 77.93.

OnKure Therapeutics Inc. - Ordinary Shares - Class A XNAS: OKUR

OnKure Therapeutics Inc. - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: OnKure Therapeutics Inc. - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: OnKure Therapeutics Inc. - Ordinary Shares - Class A
Rating: 0.86483325
Author: Trendlyne DVM scores

about

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company op...

2.32 0.12 (5.45%)

New 52W Low in past week

669.2K XNAS Volume

High volume+gain today

XNAS 20 May, 2025 4:02 PM (EDT)

Board Meeting

The next board meeting for OnKure Therapeutics Inc. - Ordinary Shares - Class A is on 30 May 2025 for the purpose of OnKure Therapeutics Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

15.3 / 100

Technically Bearish

19.3 / 100

No estimates available

OnKure Therapeutics Inc. -... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

OnKure Therapeutics Inc. - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company op...

New 52W Low in past week

High volume+gain today

SWOT Analysis

OnKure Therapeutics Inc. -... Live Price Chart

OnKure Therapeutics Inc. - Ordinary Shares - Class A FAQ

How is OnKure Therapeutics Inc. - Ordinary Shares - Class A today?

OnKure Therapeutics Inc. - Ordinary Shares - Class A today is trading in the green, and is up by 5.45% at 2.32.

How has OnKure Therapeutics Inc. - Ordinary Shares - Class A performed historically?

OnKure Therapeutics Inc. - Ordinary Shares - Class A is currently trading up 5.45% on an intraday basis. In the past week the stock rose 18.97%. stock has been down -59.30% in the past quarter and fell None% in the past year. You can view this in the overview section.